173 related articles for article (PubMed ID: 31262038)
1. Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan-Fucoidan Nanoparticles.
Choi DG; Venkatesan J; Shim MS
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262038
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery.
Huang YC; Li RY
Mar Drugs; 2014 Jul; 12(8):4379-98. PubMed ID: 25089950
[TBL] [Abstract][Full Text] [Related]
3. Soluble eggshell membrane protein-loaded chitosan/fucoidan nanoparticles for treatment of defective intestinal epithelial cells.
Lee MC; Huang YC
Int J Biol Macromol; 2019 Jun; 131():949-958. PubMed ID: 30910672
[TBL] [Abstract][Full Text] [Related]
4. Redox- and pH-Responsive Nanoparticles Release Piperlongumine in a Stimuli-Sensitive Manner to Inhibit Pulmonary Metastasis of Colorectal Carcinoma Cells.
Lee HL; Hwang SC; Nah JW; Kim J; Cha B; Kang DH; Jeong YI
J Pharm Sci; 2018 Oct; 107(10):2702-2712. PubMed ID: 29936202
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774
[TBL] [Abstract][Full Text] [Related]
6. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
Chen CH; Lin YS; Wu SJ; Mi FL
Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
[TBL] [Abstract][Full Text] [Related]
7. Effect of basic fibroblast growth factor released from chitosan-fucoidan nanoparticles on neurite extension.
Huang YC; Yang YT
J Tissue Eng Regen Med; 2016 May; 10(5):418-27. PubMed ID: 23696519
[TBL] [Abstract][Full Text] [Related]
8. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
9. Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation.
Barbosa AI; Costa Lima SA; Reis S
Int J Biol Macromol; 2019 Mar; 124():1115-1122. PubMed ID: 30521895
[TBL] [Abstract][Full Text] [Related]
10. Development of a new type of multifunctional fucoidan-based nanoparticles for anticancer drug delivery.
Lu KY; Li R; Hsu CH; Lin CW; Chou SC; Tsai ML; Mi FL
Carbohydr Polym; 2017 Jun; 165():410-420. PubMed ID: 28363567
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
Li J; Sharkey CC; King MR
Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Almutairi FM; Abd-Rabou AA; Mohamed MS
Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
[TBL] [Abstract][Full Text] [Related]
13. Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery.
Huang YC; Li RY; Chen JY; Chen JK
Carbohydr Polym; 2016 Mar; 138():114-22. PubMed ID: 26794744
[TBL] [Abstract][Full Text] [Related]
14. Pro-oxidant drug-loaded porphyrinic zirconium metal-organic-frameworks for cancer-specific sonodynamic therapy.
Truong Hoang Q; Kim M; Kim BC; Lee CY; Shim MS
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112189. PubMed ID: 34752984
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
16. Nanoencapsulation of Red Ginseng Extracts Using Chitosan with Polyglutamic Acid or Fucoidan for Improving Antithrombotic Activities.
Kim ES; Lee JS; Lee HG
J Agric Food Chem; 2016 Jun; 64(23):4765-71. PubMed ID: 27181678
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
18. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
19. A strategy to improve the solubility and bioavailability of the insoluble drug piperlongumine through albumin nanoparticles.
Niu S; Li X; Guo Z; Wan D; Liu Y; Li L; Dong M; Jia X
Pak J Pharm Sci; 2023 Mar; 36(2):483-490. PubMed ID: 37530156
[TBL] [Abstract][Full Text] [Related]
20. Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer.
Saren BN; Mahajan S; Aalhate M; Kumar R; Chatterjee E; Maji I; Gupta U; Guru SK; Singh PK
Colloids Surf B Biointerfaces; 2024 Jan; 233():113631. PubMed ID: 37979483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
